JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duksin, D.
Right arrow Articles by Bornstein, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duksin, D.
Right arrow Articles by Bornstein, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

JBC, Vol. 252, Issue 3, 955-962, Feb, 1977

Impaired conversion of procollagen to collagen by fibroblasts and bone treated with tunicamycin, an inhibitor of protein glycosylation

D. Duksin and P. Bornstein

Tunicamycin, an inhibitor of lipid carrier-dependent protein glycosylation, was used in studies of procollagen synthesis, secretion, and proteolytic modification by chick cranial bones in organ culture and by chick tendon fibroblasts in tissue culture. Tunicamycin inhibited the incorporation of D-[2-3H]mannose into procollagen by greater than 90% whereas general protein synthesis and collagen synthesis were decreased by only 10 to 20%. The procollagen synthesized in the presence of tunicamycin was secreted normally and its immunological characteristics, as detected by an antiserum to the intact protein, were unchanged. However, tunicamycin caused an accumulation of biosynthetic intermediates containing disulfide-bonded COOH-terminal extensions in both cell and bone culture. Cleavage of NH2-terminal extensions was not detectably impaired. These findings provide additional support for the involvement of more than one enzyme in the limited proteolytic conversion of procollagen to collagen.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. R. Lamand and J. F. Bateman
The Type I Collagen pro[IMAGE]1(I) COOH-terminal Propeptide N-Linked Oligosaccharide
J. Biol. Chem., July 28, 1995; 270(30): 17858 - 17865.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
R. Maheshwari, T Sreevalsan, R. Silverman, J Hay, and R. Friedman
Tunicamycin enhances the antiviral and anticellular activity of interferon
Science, March 18, 1983; 219(4590): 1339 - 1341.
[Abstract] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
D. Sabatini, D. Colman, E. Sabban, J. Sherman, T. Morimoto, G. Kreibich, and M. Adesnik
Mechanisms for the Incorporation of Proteins into the Plasma Membrane
Cold Spring Harb Symp Quant Biol, January 1, 1982; 46(0): 807 - 818.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1977 by the American Society for Biochemistry and Molecular Biology.